Literature DB >> 11269459

The role of apolipoprotein E in cognitive decline after cardiac operation.

L Steed1, R Kong, J Stygall, J Acharya, M Bolla, M J Harrison, S E Humphries, S P Newman.   

Abstract

BACKGROUND: Recently, Tardiff and colleagues have suggested that the presence of the apolipoprotein E, epsilon4 allele was associated with increased likelihood of cognitive decline after coronary artery bypass grafting. The objective of the current study was to replicate this earlier work using an increased sample size. The increased sample also enabled an analysis by individual genotype in cognitive decline after coronary artery bypass grafting.
METHODS: Apolipoprotein E genotyping was performed on 111 individuals undergoing coronary artery bypass grafting. Each participant underwent a battery of nine neuropsychological tests before operation and 4 to 7 weeks after operation.
RESULTS: Cognitive decline, assessed by both continuous Z change scores and two categoric measures of cognitive deficit, was not significantly associated with either individual apolipoprotein E genotypes or categorization by the presence or absence of the epsilon4 allele. The examination of potential moderating factors did not alter this finding.
CONCLUSIONS: This study suggests that the epsilon4 allele is not associated with cognitive decline in the weeks after coronary artery bypass grafting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11269459     DOI: 10.1016/s0003-4975(00)02511-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

Review 1.  Genetics and outcome after cardiac surgery.

Authors:  Hilary P Grocott
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 2.  Neuroprotection during cardiac surgery.

Authors:  Hilary P Grocott; Kenji Yoshitani
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

Review 3.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

4.  APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy.

Authors:  E J Heyer; D A Wilson; D H Sahlein; J Mocco; S C Williams; R Sciacca; A Rampersad; R J Komotar; J Zurica; A Benvenisty; D O Quest; G Todd; R A Solomon; E S Connolly
Journal:  Neurology       Date:  2005-10-05       Impact factor: 9.910

Review 5.  Neurodevelopmental Outcomes in Children With Congenital Heart Disease-What Can We Impact?

Authors:  Gil Wernovsky; Daniel J Licht
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

6.  Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study.

Authors:  Karsten Bartels; Yi-Ju Li; Yen-Wei Li; William D White; Daniel T Laskowitz; Miklos D Kertai; Mark Stafford-Smith; Mihai V Podgoreanu; Mark F Newman; Joseph P Mathew
Journal:  Can J Anaesth       Date:  2015-03-06       Impact factor: 5.063

7.  Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents.

Authors:  Marie-Laure Ancelin; Guilhem de Roquefeuil; Jacqueline Scali; François Bonnel; Jean-François Adam; Jean-Claude Cheminal; Jean-Paul Cristol; Anne-Marie Dupuy; Isabelle Carrière; Karen Ritchie
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 8.  Neurodevelopmental outcomes following congenital heart surgery.

Authors:  Jean A Ballweg; Gil Wernovsky; J William Gaynor
Journal:  Pediatr Cardiol       Date:  2007-01-29       Impact factor: 1.655

Review 9.  Brain protection in cardiac surgery.

Authors:  Kelly Grogan; Joshua Stearns; Charles W Hogue
Journal:  Anesthesiol Clin       Date:  2008-09

10.  The role of SOAT-1 polymorphisms in cognitive decline and delirium after bypass heart surgery.

Authors:  G I Tagarakis; F Tsolaki-Tagaraki; M Tsolaki; A Diegeler; D Kazis; E Rouska; A Papassotiropoulos
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.